Clinical Trials Browser

OTHER × Pancreatic Ductal Adenocarcinoma × PEGPH20 × Clear all

NCT04134468 2020-01-31

MRI Effects of Pegvorhyaluronidase Alfa (PEGPH20) in Pancreatic Ductal Adenocarcinoma

Phase 2 Withdrawn

Gastrointestinal

Pancreatic Ductal Adenocarcinoma